Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mustasin Rassel

1PUBLICATIONS

18CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 24, 2022

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer.

Hajrah Khawaja, Rebecca Briggs, Cheryl H Latimer

Pageof 1

Frequent Collaborators

1 joint publications

Hajrah Khawaja

1 joint publications

Rebecca Briggs

1 joint publications

Cheryl H Latimer

1 joint publications

Daryl Griffin

1 joint publications

Lyndsey Hanson

1 joint publications

Alberto Bardelli

1 joint publications

Frederica Di Nicolantonio

1 joint publications

Simon S McDade

1 joint publications

Christopher J Scott

1 joint publications

Shauna Lambe

Frequent Collaborators

1 joint publications

Hajrah Khawaja

1 joint publications

Rebecca Briggs

1 joint publications

Cheryl H Latimer

1 joint publications

Daryl Griffin

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos